去纤苷哪里有卖?
(Synonym: defibrinated sodium) has received marketing authorization from the European Commission for the treatment of severe hepatic VOD in hematopoietic stem cell transplantation (HSCT). A phase 3 randomized controlled trial of defibrination to prevent hepatic VOD in pediatric transplant patients has also been completed. Defibrotide is generally well tolerated, and its therapeutic effect has been effectively verified. Where can I buy defibrotide?
Purchasing channels for defibrotide: According to Medical Companion Travel, defibrotide has been marketed abroad. The price of defibrotide listed abroad is about 22,000. Due to the floating exchange rate, the price is different. Please consult Medical Companion Travel for the specific price! If you need defibrotide and it is inconvenient to go abroad, the most reliable way is to purchase it through a regular domestic overseas medical service institution, which will sign a guarantee contract for you. The medicine and money will not be handled by you, and will be mailed to the patient by direct mail, guaranteeing 100% authenticity!
Patients using defibrotide treatment must understand the following precautions:
1. Defibrotide needs to be administered by injection, and defibrotide must be diluted before infusion.
2. Before administration of defibrotide, confirm that the patient has not experienced clinically significant bleeding and is hemodynamically stable on no more than one vasopressor.
3. Defibrotide (alias: defibrotide sodium) should not be co-administered with other intravenous drugs in the same intravenous line at the same time.
4. Bleeding: Monitor the patient for bleeding. If significant bleeding occurs, withhold or discontinue defibrotide.
5. Hypersensitivity reaction: If a severe or life-threatening allergic reaction occurs, discontinue defibrination, treat according to standard medical care, and monitor until signs and symptoms resolve.
Contraindications: Concomitant administration with systemic anticoagulants or fibrinolytic therapy. Known hypersensitivity to or to any excipient.
Recommended related hot articles: /newsDetail/74892.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)